60.69
-0.74
(-1.20%)
At close: April 16 at 4:00:01 PM EDT
61.20
+0.51
+(0.84%)
Pre-Market: 7:43:34 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 22, 2022 | -- |
CARROLL JILL Director | Sale | Mar 21, 2024 | -- |
ELGHANDOUR RAMI Chief Executive Officer | Stock Award(Grant) | Feb 27, 2025 | 1,164,860 |
FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 21, 2022 | -- |
GILSON MICHELLE Chief Financial Officer | Sale | Jan 8, 2025 | 9,582 |
HEERY CHRISTOPHER RYAN Officer | Sale | Feb 24, 2025 | 37,486 |
PATEL KAVITA K Director | Sale | Apr 8, 2025 | -- |
SANDELL SCOTT D Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 23, 2022 | -- |
SR ONE CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Sale | May 11, 2023 | -- |
WARE OLIVIA C Director | Sale | Apr 16, 2024 | -- |
Related Tickers
NAMS NewAmsterdam Pharma Company N.V.
16.03
-0.19%
RARE Ultragenyx Pharmaceutical Inc.
34.98
-1.02%
PCVX Vaxcyte, Inc.
29.12
-3.67%
NUVL Nuvalent, Inc.
69.97
-1.14%
LEGN Legend Biotech Corporation
33.46
-0.83%
AKRO Akero Therapeutics, Inc.
37.44
-1.68%
JANX Janux Therapeutics, Inc.
28.69
-1.27%
ASND Ascendis Pharma A/S
158.15
+2.75%
APGE Apogee Therapeutics, Inc.
32.04
-2.47%
KYMR Kymera Therapeutics, Inc.
25.02
-1.73%